These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10776703)

  • 1. Iron overload in thalassaemias and genetic haemochromatosis.
    Aguilar-Martinez P; Schved JF; Badens C; Thuret I; Michel G; Neonato MG; Peltier JY; Girot R; Pissard S; Galacteros F; Bachir D; Rose C; Picot MC; Denamur E; Elion J
    Eur J Haematol; 2000 Apr; 64(4):279-80. PubMed ID: 10776703
    [No Abstract]   [Full Text] [Related]  

  • 2. Late-onset Hemochromatosis: Co-inheritance of β-thalassemia and Hereditary Hemochromatosis in a Chinese Family: A Case Report and Epidemiological Analysis of Diverse Populations.
    Yang J; Lun Y; Shuai X; Liu T; Wu Y
    Intern Med; 2018 Dec; 57(23):3433-3438. PubMed ID: 28943547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revisiting various iron overload syndromes after the haemochromatosis gene discovery.
    Worwood M
    J Hepatol; 1998; 28 Suppl 1():26-7. PubMed ID: 9575446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of co-inheritance of β-thalassemia and hemochromatosis mutations on iron overload.
    López-Escribano H; Ferragut JF; Parera MM; Guix P; Castro JA; Ramon MM; Picornell A
    Hemoglobin; 2012; 36(1):85-92. PubMed ID: 22122796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the role of hepcidin, an antimicrobial and iron regulatory peptide, in increased iron absorption in beta-thalassemia.
    Breda L; Gardenghi S; Guy E; Rachmilewitz EA; Weizer-Stern O; Adamsky K; Amariglio N; Rechavi G; Giardina PJ; Grady RW; Rivella S
    Ann N Y Acad Sci; 2005; 1054():417-22. PubMed ID: 16339690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron-mediated cardiovascular injury.
    Horwitz LD; Rosenthal EA
    Vasc Med; 1999; 4(2):93-9. PubMed ID: 10406456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Disease caused by iron overload associated to minor beta thalassemia].
    García Pont J; Moreu Araño I; Asensio Montoro A; Rueda García A
    An Med Interna; 1993 Apr; 10(4):203. PubMed ID: 8513091
    [No Abstract]   [Full Text] [Related]  

  • 8. H63D mutation in the HFE gene increases iron overload in beta-thalassemia carriers.
    Melis MA; Cau M; Deidda F; Barella S; Cao A; Galanello R
    Haematologica; 2002 Mar; 87(3):242-5. PubMed ID: 11869934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in understanding haemochromatosis: a transition state.
    Robson KJ; Merryweather-Clarke AT; Cadet E; Viprakasit V; Zaahl MG; Pointon JJ; Weatherall DJ; Rochette J
    J Med Genet; 2004 Oct; 41(10):721-30. PubMed ID: 15466004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of hemochromatosis mutations on iron overload of thalassemia major.
    Longo F; Zecchina G; Sbaiz L; Fischer R; Piga A; Camaschella C
    Haematologica; 1999 Sep; 84(9):799-803. PubMed ID: 10477452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemochromatosis in patients with beta-thalassaemia trait.
    Piperno A; Mariani R; Arosio C; Vergani A; Bosio S; Fargion S; Sampietro M; Girelli D; Fraquelli M; Conte D; Fiorelli G; Camaschella C
    Br J Haematol; 2000 Dec; 111(3):908-14. PubMed ID: 11122155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterozygosity for the H63D mutation in the hereditary hemochromatosis (HFE) gene may lead into severe iron overload in beta-thalassemia minor: observations in a thalassemic kindred.
    Ruiz-Argüelles GJ; Garcés-Eisele J; Reyes-Núñez V; Sánchez-Anzaldo J; Ruiz-Delgado GJ; Jiménez-González C; Carrera B
    Rev Invest Clin; 2001; 53(2):117-20. PubMed ID: 11421105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron and glucose homeostasis: new lessons from hereditary haemochromatosis.
    Wilson JG
    Diabetologia; 2006 Jul; 49(7):1459-61. PubMed ID: 16752163
    [No Abstract]   [Full Text] [Related]  

  • 14. Liver iron concentrations and urinary hepcidin in beta-thalassemia.
    Origa R; Galanello R; Ganz T; Giagu N; Maccioni L; Faa G; Nemeth E
    Haematologica; 2007 May; 92(5):583-8. PubMed ID: 17488680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semiquantitative and qualitative assessment of hepatic iron in patients with chronic viral hepatitis: relation with grading, staging and haemochromatosis mutations.
    Vergani A; Bovo G; Trombini P; Caronni N; Arosio C; Malosio I; Fossati L; Roffi L; Piperno A
    Ital J Gastroenterol Hepatol; 1999; 31(5):395-400. PubMed ID: 10470600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 3 hemochromatosis and beta-thalassemia trait.
    Riva A; Mariani R; Bovo G; Pelucchi S; Arosio C; Salvioni A; Vergani A; Piperno A
    Eur J Haematol; 2004 May; 72(5):370-4. PubMed ID: 15059075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron overload in light of the identification of a haemochromatosis gene.
    Hollán S
    Haematologia (Budap); 1997; 28(3):109-16. PubMed ID: 9283910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compound heterozygosity for haemochromatosis gene mutations and hepatic iron overload in allogeneic bone marrow transplant recipients.
    Grigg AP; Bhathal PS
    Pathology; 2001 Feb; 33(1):44-9. PubMed ID: 11280607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C282Y and H63D mutations of the haemochromatosis gene in patients with iron overload.
    Jorquera F; Domínguez A; Díaz-Golpe V; Espinel J; Muñoz F; Herrera A; Fernández-Gundín MJ; Vivas S; Olcoz JL
    Rev Esp Enferm Dig; 2001 May; 93(5):293-302. PubMed ID: 11488107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective release of Hepcidin not defective synthesis is the primary pathogenic mechanism in HFE-Haemochromatosis.
    Arnold J; Sangwaiya A; Bhatkal B; Arnold A
    Med Hypotheses; 2008; 70(6):1197-200. PubMed ID: 18054440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.